These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20965983)
21. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection. Zou P; Liu W; Chen YH Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332 [TBL] [Abstract][Full Text] [Related]
22. A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge. Kumar P; Khanna M; Kumar B; Rajput R; Banerjea AC Antiviral Res; 2012 Jan; 93(1):78-85. PubMed ID: 22086129 [TBL] [Abstract][Full Text] [Related]
23. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Ernst WA; Kim HJ; Tumpey TM; Jansen AD; Tai W; Cramer DV; Adler-Moore JP; Fujii G Vaccine; 2006 Jun; 24(24):5158-68. PubMed ID: 16713037 [TBL] [Abstract][Full Text] [Related]
25. Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice. Alvarez P; Zylberman V; Ghersi G; Boado L; Palacios C; Goldbaum F; Mattion N Vaccine; 2013 Jan; 31(5):806-12. PubMed ID: 23246552 [TBL] [Abstract][Full Text] [Related]
26. Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles. Yong CY; Yeap SK; Ho KL; Omar AR; Tan WS Int J Nanomedicine; 2015; 10():2751-63. PubMed ID: 25897220 [TBL] [Abstract][Full Text] [Related]
27. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315 [TBL] [Abstract][Full Text] [Related]
28. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice. Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634 [TBL] [Abstract][Full Text] [Related]
29. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Neirynck S; Deroo T; Saelens X; Vanlandschoot P; Jou WM; Fiers W Nat Med; 1999 Oct; 5(10):1157-63. PubMed ID: 10502819 [TBL] [Abstract][Full Text] [Related]
30. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. Zharikova D; Mozdzanowska K; Feng J; Zhang M; Gerhard W J Virol; 2005 Jun; 79(11):6644-54. PubMed ID: 15890902 [TBL] [Abstract][Full Text] [Related]
31. An influenza A virus vaccine based on an M2e-modified alphavirus. Krishnavajhala HR; Williams J; Heidner H Arch Virol; 2018 Feb; 163(2):483-488. PubMed ID: 29079954 [TBL] [Abstract][Full Text] [Related]
32. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs. Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090 [TBL] [Abstract][Full Text] [Related]
33. Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. Andersson AM; Håkansson KO; Jensen BA; Christensen D; Andersen P; Thomsen AR; Christensen JP PLoS One; 2012; 7(10):e46395. PubMed ID: 23049700 [TBL] [Abstract][Full Text] [Related]
34. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets. Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664 [TBL] [Abstract][Full Text] [Related]
35. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654 [TBL] [Abstract][Full Text] [Related]
36. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus]. Xu H; Wang YW; Tang YH; Zheng QS; Hou JB Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of anti-influenza efficiency of polyclonal IgG antibodies specific to the ectodomain of M2 protein of influenza A virus by passive immunization of mice. Király J; Varečková E; Mucha V; Kostolanský F Acta Virol; 2011; 55(3):261-5. PubMed ID: 21978160 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge. Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215 [TBL] [Abstract][Full Text] [Related]
39. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411 [TBL] [Abstract][Full Text] [Related]
40. Universal influenza A vaccine: optimization of M2-based constructs. De Filette M; Min Jou W; Birkett A; Lyons K; Schultz B; Tonkyro A; Resch S; Fiers W Virology; 2005 Jun; 337(1):149-61. PubMed ID: 15914228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]